Kenvue Inc. (KVUE) Yield on Cost (YOC): 4.51%
The yield on cost (YOC) for Kenvue Inc. (KVUE) is 4.51%.
KVUE Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
4.51%
Yield on Cost for KVUE
KVUE now pays $0.83 per share a year. Measured against the price it actually traded at back then, a long-term holder is earning:
| If you bought | Price then | Yield on cost today |
|---|---|---|
| 3 years ago(2023-06-23) | $26.48 | 3.13% |
| 1 year ago(2025-06-23) | $21.37 | 3.88% |
| Buying today(at $18.41) | $18.41 | 4.51% |
Yield on Cost Calculator
Try your own purchase price, dividend and growth rate for Kenvue Inc. (KVUE).
Starting Yield
4.51%
Ending YOC
14.30%
Year 15 Dividend
$2.63
Cum. Dividends Recd.
$24.34
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $0.83 | — | 4.51% | $0.00 |
| Year 1 | $0.90 | +8.00% | 4.87% | $0.90 |
| Year 2 | $0.97 | +8.00% | 5.26% | $1.86 |
| Year 3 | $1.05 | +8.00% | 5.68% | $2.91 |
| Year 4 | $1.13 | +8.00% | 6.13% | $4.04 |
| Year 5 | $1.22 | +8.00% | 6.62% | $5.26 |
| Year 6 | $1.32 | +8.00% | 7.15% | $6.58 |
| Year 7 | $1.42 | +8.00% | 7.73% | $8.00 |
| Year 8 | $1.54 | +8.00% | 8.34% | $9.53 |
| Year 9 | $1.66 | +8.00% | 9.01% | $11.19 |
| Year 10 | $1.79 | +8.00% | 9.73% | $12.99 |
| Year 11 | $1.94 | +8.00% | 10.51% | $14.92 |
| Year 12 | $2.09 | +8.00% | 11.35% | $17.01 |
| Year 13 | $2.26 | +8.00% | 12.26% | $19.27 |
| Year 14 | $2.44 | +8.00% | 13.24% | $21.71 |
| Year 15 | $2.63 | +8.00% | 14.30% | $24.34 |
Kenvue Inc. Yield on Cost (YOC) Formula & Definition
Yield on cost is the dividend yield measured against your original purchase price, not today's price. As a company raises its dividend, the yield on what you actually paid keeps rising even when the market yield holds steady.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Kenvue Inc. Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for Kenvue Inc. (KVUE)?
- The yield on cost (YOC) for KVUE stock is 4.51%.
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry